What is the Potential Impact of Reviewing Post-procedure Images With Patients Following Interventional Spine Procedures.

Sponsor
University of Michigan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05884684
Collaborator
(none)
200
1
2
6
33.3

Study Details

Study Description

Brief Summary

The purpose of this study is to explore the impact of spine physicians reviewing post-procedural fluoroscopic images with patients. The outcome measure to be assessed will be the potential impact the patient satisfaction and the patient's global impression of change (PGIC) 2 weeks after the spine procedure.

Condition or Disease Intervention/Treatment Phase
  • Other: Reviewing Imaging with Participant
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
A spine physician will not discuss images with the first group of participants immediately following their procedure. A spine physician will discuss images with the second group of participants immediately following their procedure.A spine physician will not discuss images with the first group of participants immediately following their procedure. A spine physician will discuss images with the second group of participants immediately following their procedure.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
What is the Potential Impact of Reviewing Post-procedure Images With Patients Following Interventional Spine Procedures.
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Post-Procedural Images Not Discussed with Participants

During a lumbar epidural steroid injection under fluoroscopic guidance, images are taken as part of the procedure. Following the procedure, the surgeon who performed it will not discuss the images with the participants in this arm. If participants request an explanation of the images, they will not be included in the analysis.

Other: Post-Procedural Images Discussed with Participants

During a lumbar epidural steroid injection under fluoroscopic guidance, images are taken as part of the procedure. Following the procedure, the surgeon who performed it will discuss the images with the participants in this arm.

Other: Reviewing Imaging with Participant
Post-operatively, the images taken during the procedure will be reviewed with the participant.

Outcome Measures

Primary Outcome Measures

  1. Modified Press Gainey Satisfaction (PGS) Questionnaire [Up to 2 hours following procedure in the post-op area]

    Patient satisfaction as measured by a modified version of the PGS Questionnaire. The questionnaire is comprised of 9 questions measuring general patient satisfaction with the care experience. Each question is on a scale of 1 (very poor) to 5 (very good). The lowest possible score of the PGS is 9, and the highest possible score is 45. The lower the total score, the poorer the patient's satisfaction, while the higher the score, the higher the patient's satisfaction.

Secondary Outcome Measures

  1. Patient Global Impression of Change (PGIC) [2 weeks following procedure]

    The PGIC is a scale participants use to rate the level of change they have experienced following treatment. The PGIC is a 7-point scale from 1 (very much better) to 7 (very much worse). After making this selection, participants then rate the percentage of how their condition is following the transforaminal epidural steroid injection compared to before, with 10% being "a little better" and 100% being "very much better."

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Lumbosacral radiculopathy symptoms

  • Received transforaminal epidural steroid injection

Exclusion Criteria:
  • Patients who will be sedated for transforaminal epidural steroid injection

  • Unable to read or understand English-language survey

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan - Burlington Building Ann Arbor Michigan United States 48108

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Tahsin Choudhury, DO, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tahsin Choudhury, Principal Investigator, University of Michigan
ClinicalTrials.gov Identifier:
NCT05884684
Other Study ID Numbers:
  • HUM00216837
First Posted:
Jun 1, 2023
Last Update Posted:
Jun 1, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tahsin Choudhury, Principal Investigator, University of Michigan

Study Results

No Results Posted as of Jun 1, 2023